The University of Chicago Header Logo

Connection

Fredric L. Coe to Calcium

This is a "connection" page, showing publications Fredric L. Coe has written about Calcium.
Connection Strength

5.534
  1. Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Sep 15; 305(6):F853-60.
    View in: PubMed
    Score: 0.327
  2. Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant. 2012 Jul; 27(7):2847-53.
    View in: PubMed
    Score: 0.300
  3. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75.
    View in: PubMed
    Score: 0.208
  4. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int. 2006 Oct; 70(8):1463-7.
    View in: PubMed
    Score: 0.203
  5. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4.
    View in: PubMed
    Score: 0.168
  6. Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023 12 01; 325(6):F811-F816.
    View in: PubMed
    Score: 0.166
  7. Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1059-1067.
    View in: PubMed
    Score: 0.162
  8. Vitamin D and Parathyroid Hormone Levels in CKD. Am J Kidney Dis. 2023 01; 81(1):122-124.
    View in: PubMed
    Score: 0.153
  9. Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7.
    View in: PubMed
    Score: 0.150
  10. Does a failure of crystal inhibition cause calcium renal stones? Nephron. 2002 Apr; 90(4):361-4.
    View in: PubMed
    Score: 0.149
  11. Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1166-1173.
    View in: PubMed
    Score: 0.132
  12. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int. 1997 Mar; 51(3):640-5.
    View in: PubMed
    Score: 0.105
  13. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016 09; 12(9):519-33.
    View in: PubMed
    Score: 0.101
  14. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016 Dec; 29(6):715-734.
    View in: PubMed
    Score: 0.101
  15. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995 Dec; 48(6):1705-13.
    View in: PubMed
    Score: 0.096
  16. Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92.
    View in: PubMed
    Score: 0.093
  17. Idiopathic hypercalciuria: the contribution of Dr. Jacob Lemann, Jr. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S59-69.
    View in: PubMed
    Score: 0.089
  18. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994 Jan; 45(1):58-65.
    View in: PubMed
    Score: 0.084
  19. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Aug 15; 305(4):F592-9.
    View in: PubMed
    Score: 0.081
  20. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8.
    View in: PubMed
    Score: 0.074
  21. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int. 1992 Jan; 41(1):139-42.
    View in: PubMed
    Score: 0.073
  22. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8.
    View in: PubMed
    Score: 0.068
  23. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63.
    View in: PubMed
    Score: 0.067
  24. Evidence for altered renal tubule function in idiopathic calcium stone formers. Urol Res. 2010 Aug; 38(4):263-9.
    View in: PubMed
    Score: 0.066
  25. Does idiopathic hypercalciuria trigger calcium-sensing receptor-mediated protection from urinary supersaturation? J Am Soc Nephrol. 2009 Aug; 20(8):1657-9.
    View in: PubMed
    Score: 0.062
  26. Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int. 1989 Jul; 36(1):108-13.
    View in: PubMed
    Score: 0.062
  27. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94.
    View in: PubMed
    Score: 0.058
  28. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988 Jun; 33(6):1140-6.
    View in: PubMed
    Score: 0.057
  29. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008 Mar; 28(2):120-32.
    View in: PubMed
    Score: 0.056
  30. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987 Nov; 32(5):749-53.
    View in: PubMed
    Score: 0.055
  31. Effects of medium pH on duodenal and ileal calcium active transport in the rat. Am J Physiol. 1986 Nov; 251(5 Pt 1):G695-700.
    View in: PubMed
    Score: 0.051
  32. Ca and P regulation of 1,25(OH)2D3 synthesis by vitamin D-replete rat tubules during acidosis. Am J Physiol. 1986 Nov; 251(5 Pt 2):F911-8.
    View in: PubMed
    Score: 0.051
  33. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9.
    View in: PubMed
    Score: 0.051
  34. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90.
    View in: PubMed
    Score: 0.050
  35. Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption. Am J Physiol. 1986 Jul; 251(1 Pt 2):F17-24.
    View in: PubMed
    Score: 0.050
  36. Recurrent renal calculi. Causes and prevention. Hosp Pract (Off Ed). 1986 Mar 30; 21(3A):49-57.
    View in: PubMed
    Score: 0.049
  37. Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9.
    View in: PubMed
    Score: 0.048
  38. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest. 1985 Oct; 76(4):1599-604.
    View in: PubMed
    Score: 0.048
  39. Response of serum 1,25(OH)2D3 to variation of ionized calcium during chronic acidosis. Am J Physiol. 1985 Sep; 249(3 Pt 2):F361-5.
    View in: PubMed
    Score: 0.047
  40. Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae. Am J Physiol. 1985 Jun; 248(6 Pt 2):F785-9.
    View in: PubMed
    Score: 0.047
  41. Role of fetal 1,25-dihydroxyvitamin D production in intrauterine phosphorus and calcium homeostasis. Pediatr Res. 1985 Jun; 19(6):566-9.
    View in: PubMed
    Score: 0.047
  42. Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption. Am J Physiol. 1984 Nov; 247(5 Pt 2):F746-52.
    View in: PubMed
    Score: 0.045
  43. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab. 2004 Oct; 89(10):4937-43.
    View in: PubMed
    Score: 0.044
  44. Treatment of hypercalciuria. N Engl J Med. 1984 Jul 12; 311(2):116-8.
    View in: PubMed
    Score: 0.044
  45. Pathophysiology of hypercalciuria. Am J Physiol. 1984 Jul; 247(1 Pt 2):F1-13.
    View in: PubMed
    Score: 0.044
  46. Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria. J Pediatr. 1983 Dec; 103(6):932-5.
    View in: PubMed
    Score: 0.042
  47. Effects of pH on bone calcium and proton fluxes in vitro. Am J Physiol. 1983 Aug; 245(2):F204-9.
    View in: PubMed
    Score: 0.041
  48. Effects of trifluoperazine, ouabain, and ethacrynic acid on intestinal calcium transport. Am J Physiol. 1983 Feb; 244(2):G111-5.
    View in: PubMed
    Score: 0.040
  49. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003 Feb; 63(2):662-9.
    View in: PubMed
    Score: 0.040
  50. Effects of calcium intake on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. Trans Assoc Am Physicians. 1983; 96:225-33.
    View in: PubMed
    Score: 0.039
  51. Idiopathic hypercalciuria. Henry Ford Hosp Med J. 1983; 31(4):229-30.
    View in: PubMed
    Score: 0.039
  52. Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
    View in: PubMed
    Score: 0.039
  53. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int. 2002 May; 61(5):1821-9.
    View in: PubMed
    Score: 0.038
  54. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002 Mar; 61(3):975-87.
    View in: PubMed
    Score: 0.037
  55. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med. 1982 Jan; 72(1):25-32.
    View in: PubMed
    Score: 0.037
  56. Effects of somatostatin on intestinal calcium transport in the rat. Am J Physiol. 1981 Sep; 241(3):G215-21.
    View in: PubMed
    Score: 0.036
  57. Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44.
    View in: PubMed
    Score: 0.035
  58. Kinetic characteristics of calcium absorption and secretion by rat colon. Am J Physiol. 1981 May; 240(5):G350-4.
    View in: PubMed
    Score: 0.035
  59. Clinical use of cystine supersaturation measurements. J Urol. 2000 Nov; 164(5):1481-5.
    View in: PubMed
    Score: 0.034
  60. Idiopathic hypercalciuria in calcium nephrolithiasis. Dis Mon. 1980 Sep; 26(12):1-36.
    View in: PubMed
    Score: 0.033
  61. Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10.
    View in: PubMed
    Score: 0.033
  62. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 1999 Oct; 56(4):1505-16.
    View in: PubMed
    Score: 0.031
  63. Familial idiopathic hypercalciuria. N Engl J Med. 1979 Feb 15; 300(7):337-40.
    View in: PubMed
    Score: 0.030
  64. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int. 1999 Feb; 55(2):602-12.
    View in: PubMed
    Score: 0.030
  65. Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3.
    View in: PubMed
    Score: 0.029
  66. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
    View in: PubMed
    Score: 0.028
  67. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26.
    View in: PubMed
    Score: 0.028
  68. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8.
    View in: PubMed
    Score: 0.028
  69. Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. Am J Physiol. 1977 Nov; 233(5):F455-63.
    View in: PubMed
    Score: 0.028
  70. The natural history of calcium urolithiasis. JAMA. 1977 Oct 03; 238(14):1519-23.
    View in: PubMed
    Score: 0.027
  71. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10.
    View in: PubMed
    Score: 0.027
  72. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976 Dec; 29(12):793-800.
    View in: PubMed
    Score: 0.026
  73. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol. 2015 Oct 15; 16:163.
    View in: PubMed
    Score: 0.024
  74. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1):63-70.
    View in: PubMed
    Score: 0.023
  75. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50.
    View in: PubMed
    Score: 0.023
  76. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis. Acta Urol Belg. 1994 Jun; 62(2):25-9.
    View in: PubMed
    Score: 0.022
  77. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron. 1994; 67(4):414-8.
    View in: PubMed
    Score: 0.021
  78. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31.
    View in: PubMed
    Score: 0.020
  79. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest. 1973 Jan; 52(1):134-42.
    View in: PubMed
    Score: 0.020
  80. Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary? Trans Assoc Am Physicians. 1971; 84:152-61.
    View in: PubMed
    Score: 0.017
  81. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
    View in: PubMed
    Score: 0.015
  82. Elevated 1,25(OH)2D3, intestinal absorption, and renal mineral conservation in male rats. Am J Physiol. 1984 Feb; 246(2 Pt 2):F140-5.
    View in: PubMed
    Score: 0.011
  83. Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403.
    View in: PubMed
    Score: 0.010
  84. Effects of metabolic acidosis on PTH and 1,25(OH)2D3 response to low calcium diet. Am J Physiol. 1982 Dec; 243(6):F570-5.
    View in: PubMed
    Score: 0.010
  85. Effects of chlorothiazide on 1,25-dihydroxyvitamin D3, parathyroid hormone, and intestinal calcium absorption in the rat. Am J Physiol. 1982 Jun; 242(6):G575-81.
    View in: PubMed
    Score: 0.009
  86. Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med. 1982 May 06; 306(18):1088-91.
    View in: PubMed
    Score: 0.009
  87. Effects of chlorothiazide administration and dietary calcium restriction on parathyroid function, vitamin D metabolism and intestinal calcium absorption in the rat. Adv Exp Med Biol. 1982; 151:501-7.
    View in: PubMed
    Score: 0.009
  88. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24.
    View in: PubMed
    Score: 0.009
  89. Prevention of kidney stones. Am J Med. 1981 Oct; 71(4):514-6.
    View in: PubMed
    Score: 0.009
  90. [Vitamin D physiology and its application to disorders of calcium metabolism]. Recenti Prog Med. 1981 Feb; 70(2):119-40.
    View in: PubMed
    Score: 0.009
  91. Effects of diet calcium and 1,25-dihydroxyvitamin D3 on colon calcium active transport. Am J Physiol. 1980 Feb; 238(2):G75-8.
    View in: PubMed
    Score: 0.008
  92. Treatment of renal calculi. Adv Intern Med. 1980; 26:373-92.
    View in: PubMed
    Score: 0.008
  93. Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb; 90(2):180-4.
    View in: PubMed
    Score: 0.007
  94. Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10.
    View in: PubMed
    Score: 0.007
  95. Evidence for mild reversible hyperparathyroidism in distal renal tubular acidosis. Arch Intern Med. 1975 Nov; 135(11):1485-9.
    View in: PubMed
    Score: 0.006
  96. Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man. Kidney Int. 1975 Oct; 8(4):263-73.
    View in: PubMed
    Score: 0.006
  97. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med. 1975 Sep; 149(4):926-9.
    View in: PubMed
    Score: 0.006
  98. Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch Intern Med. 1974 Aug; 134(2):262-5.
    View in: PubMed
    Score: 0.005
  99. Chronic renal failure. Clin Symp. 1973; 25(1):2-32.
    View in: PubMed
    Score: 0.005
  100. A diagnostic approach to the patient with renal stones. Med Times. 1970 Oct; 98(10):87-94.
    View in: PubMed
    Score: 0.004
  101. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem. 1983 Oct 25; 258(20):12594-600.
    View in: PubMed
    Score: 0.003
  102. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7.
    View in: PubMed
    Score: 0.002
  103. Nutritional and metabolic complications in a patient with Crohn's disease and ileal resection. Gastroenterology. 1980 May; 78(5 Pt 1):1069-79.
    View in: PubMed
    Score: 0.002
  104. Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med. 1974 May; 56(5):704-14.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.